SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-17-000342
Filing Date
2017-01-10
Accepted
2017-01-10 17:27:25
Documents
7
Period of Report
2017-01-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 31318
2 ex1-1.htm EX-1.1 299679
3 ex4-1.htm EX-4.1 94066
4 ex5-1.htm EX-5.1 15563
5 ex99-1.htm EX-99.1 10326
6 image_001.jpg GRAPHIC 40610
7 image_002.jpg GRAPHIC 10530
  Complete submission text file 0001493152-17-000342.txt   522667
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences Inc (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36268 | Film No.: 17521465
SIC: 2835 In Vitro & In Vivo Diagnostic Substances